Tenaya Therapeutics, Inc. (TNYA) Tops Q2 EPS by 5c

Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q2 EPS of ($0.34), $0.05 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.

You May Also Be Interested In

• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Evolv Technology adds 70 customers in Q2, expands bag screening